Further experiments indicated that CTGF exerts an anti-angiogenic effect in NSCLC by the reduction of hypoxia-inducible factor 1α (HIF-1α) protein stability (Chang et al. 2006). The gene discussed is CCN2; the disease is non-small cell lung carcinoma.